Furthermore, methylation of the PITX2 promoter was also associated with poor patient outcome in estrogen receptor alpha positive, HER-2/neu-negative breast cancer patients positive for lymph node metastasis when treated with an anthracycline-based adjuvant chemotherapy [174]. This evidence concerns the gene ESR1 and metastatic malignant neoplasm in the lymph nodes.